Get the Stockscreener App
1.26
3.08%
-0.04
60 Degrees Pharmaceuticals Inc stock is traded at $1.26, with a volume of 32,919.
It is down -3.08% in the last 24 hours and down -5.26% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
See More
Previous Close:
$1.30
Open:
$1.28
24h Volume:
32,919
Relative Volume:
0.06
Market Cap:
$5.17M
Revenue:
$502.40K
Net Income/Loss:
$-7.91M
P/E Ratio:
-0.1264
EPS:
-9.972
Net Cash Flow:
$-4.32M
1W Performance:
-4.55%
1M Performance:
-5.26%
6M Performance:
-44.00%
1Y Performance:
-86.88%
1-Day Range:
$1.26
$1.2892
1-Week Range:
$1.26
$1.35
52-Week Range:
$1.24
$12.70
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.26 | 4.19M | 502.40K | -7.91M | -4.32M | -9.972 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
Using Ichimoku Cloud for 60 Degrees Pharmaceuticals Inc. Equity Warrant technicals2025 Winners & Losers & High Accuracy Trade Alerts - Newser
How to forecast 60 Degrees Pharmaceuticals Inc. Equity Warrant trends using time seriesWeekly Trend Report & Entry and Exit Point Strategies - Newser
Key metrics from 60 Degrees Pharmaceuticals Inc. Equity Warrant’s quarterly dataGold Moves & Short-Term Swing Trade Alerts - Newser
Can swing trading help recover from 60 Degrees Pharmaceuticals Inc. lossesJuly 2025 Market Mood & Pattern Based Trade Signal System - Newser
Quantitative breakdown of 60 Degrees Pharmaceuticals Inc. Equity Warrant recent moveQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
Has 60 Degrees Pharmaceuticals Inc. found a price floorWeekly Market Report & Reliable Price Breakout Alerts - Newser
Using Bollinger Bands to evaluate 60 Degrees Pharmaceuticals Inc. Equity WarrantTrade Risk Report & Growth Oriented Trade Recommendations - Newser
Earnings visualization tools for 60 Degrees Pharmaceuticals Inc.2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Custom strategy builders for tracking 60 Degrees Pharmaceuticals Inc.2025 Technical Patterns & AI Driven Price Predictions - Newser
How to recover losses in 60 Degrees Pharmaceuticals Inc. Equity Warrant stockAnalyst Downgrade & Risk Managed Investment Signals - Newser
60 Degrees Pharmaceuticals Inc. Equity Warrant stock trendline breakdownQuarterly Performance Summary & Accurate Technical Buy Alerts - Newser
Measuring 60 Degrees Pharmaceuticals Inc. Equity Warrant’s beta against major indicesM&A Rumor & Long-Term Safe Return Strategies - Newser
Analyzing net buyer seller activity in 60 Degrees Pharmaceuticals Inc.Wall Street Watch & Weekly Top Gainers Trade List - Newser
60 Degrees Pharmaceuticals Inc. stock retracement – recovery analysisQuarterly Growth Report & Capital Efficient Trade Techniques - Newser
Should you hold or exit 60 Degrees Pharmaceuticals Inc. nowGold Moves & Free AI Powered Buy and Sell Recommendations - Newser
Should you wait for a breakout in 60 Degrees Pharmaceuticals Inc. Equity Warrant2025 Technical Patterns & Growth Focused Stock Pick Reports - Newser
60 Degrees Pharma to begin trial of tafenoquine for chronic babesiosis - Investing.com
First Potential Treatment for Chronic Babesiosis: 60 Degrees Pharma Launches Key Phase 2 Trial at Mount Sinai - Stock Titan
What’s the recovery path for long term holders of 60 Degrees Pharmaceuticals Inc.Market Movers & Low Drawdown Momentum Ideas - Newser
Real time breakdown of 60 Degrees Pharmaceuticals Inc. stock performanceJuly 2025 Intraday Action & AI Enhanced Market Trend Forecasts - Newser
Does 60 Degrees Pharmaceuticals Inc. qualify in momentum factor screeningJuly 2025 PostEarnings & Weekly Chart Analysis and Guides - Newser
Is This the Dip to Buy in 60 Degrees Pharmaceuticals Inc.Weekly Trade Review & AI Powered Buy/Sell Recommendations - newsyoung.net
Strategies to average down on 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - Newser
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant rally from current levelsWeekly Earnings Recap & Accurate Intraday Trading Signals - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant stock ready for a breakoutPortfolio Return Report & Fast Gain Swing Trade Alerts - Newser
60 Degrees Pharmaceuticals Reports Q2 2025 Earnings - MSN
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant Escape Recent Bear Channel2025 Market Outlook & AI Enhanced Trade Execution Alerts - newsyoung.net
60 Degrees Pharmaceuticals: Navigating Liquidity Risks and High-Stakes Clinical Potential in a Small-Cap Biotech Play - AInvest
60 Degrees Pharmaceuticals Second Quarter 2025 Earnings: Revenues Disappoint - Yahoo Finance
60 Degrees Pharmaceuticals Inc. Pullback Analyzed — Is It Time to Exit2025 Analyst Calls & Weekly Market Pulse Updates - beatles.ru
Using flow based indicators on 60 Degrees Pharmaceuticals Inc.Gap Up & Risk Controlled Stock Alerts - Newser
Can 60 Degrees Pharmaceuticals Inc. Equity Warrant recover in the next quarterWeekly Trade Analysis & High Accuracy Swing Entry Alerts - Newser
Analyzing 60 Degrees Pharmaceuticals Inc. with risk reward ratio chartsJuly 2025 Opening Moves & Advanced Technical Signal Analysis - Newser
Can you recover from losses in 60 Degrees Pharmaceuticals Inc.2025 Market Sentiment & AI Forecast Swing Trade Picks - Newser
Is a relief rally coming for 60 Degrees Pharmaceuticals Inc. Equity Warrant holdersEarnings Overview Report & Safe Entry Point Identification - Newser
Reversal indicators forming on 60 Degrees Pharmaceuticals Inc. Equity Warrant stockJuly 2025 Intraday Action & Fast Gain Stock Tips - Newser
Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc.Trade Signal Summary & Daily Momentum Trading Reports - Newser
Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a candidate for recovery playVolume Spike & Proven Capital Preservation Methods - Newser
Published on: 2025-08-17 15:22:54 - Newser
What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackWeekly Trend Summary & Low Risk High Win Rate Stock Picks - Newser
Published on: 2025-08-13 00:13:33 - Newser
What moving averages say about 60 Degrees Pharmaceuticals Inc. Equity WarrantWatch List & Stepwise Entry and Exit Trade Signals - Newser
Can trapped investors hope for a rebound in 60 Degrees Pharmaceuticals Inc.2025 Trade Ideas & Fast Exit and Entry Trade Guides - Newser
How sentiment analysis helps forecast 60 Degrees Pharmaceuticals Inc.Portfolio Profit Report & Verified Swing Trading Watchlists - Newser
Using economic indicators to assess 60 Degrees Pharmaceuticals Inc. potentialQuarterly Earnings Summary & High Yield Stock Recommendations - Newser
What to do if you’re stuck in 60 Degrees Pharmaceuticals Inc. Equity WarrantLayoff News & Free Technical Confirmation Trade Alerts - Newser
Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc. Equity WarrantJuly 2025 Drop Watch & Free Community Supported Trade Ideas - Newser
What momentum shifts mean for 60 Degrees Pharmaceuticals Inc. Equity WarrantPortfolio Risk Summary & Fast Moving Trade Plans - Newser
60 Degrees Pharmaceuticals Inc. stock daily chart insights2025 Volatility Report & Proven Capital Preservation Tips - Newser
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| XU CHERYL | Director |
Dec 13 '24 |
Buy |
1.56 |
6,000 |
9,375 |
52,078 |
| XU CHERYL | Director |
Dec 12 '24 |
Buy |
1.82 |
5,000 |
9,125 |
46,078 |
| XU CHERYL | Director |
Dec 16 '24 |
Buy |
1.45 |
2,000 |
2,900 |
54,078 |
| DOW GEOFFREY S | President and CEO |
Dec 09 '24 |
Buy |
1.27 |
35,823 |
45,563 |
94,580 |
| DOW GEOFFREY S | President and CEO |
Dec 06 '24 |
Buy |
1.20 |
20,579 |
24,672 |
58,757 |
| DOW GEOFFREY S | President and CEO |
Dec 05 '24 |
Buy |
1.11 |
17,549 |
19,520 |
38,178 |
| DOW GEOFFREY S | President and CEO |
Nov 21 '24 |
Buy |
0.91 |
3,500 |
3,195 |
20,629 |
| DOW GEOFFREY S | President and CEO |
Nov 19 '24 |
Buy |
0.90 |
2,500 |
2,248 |
16,129 |
| DOW GEOFFREY S | President and CEO |
Nov 20 '24 |
Buy |
0.92 |
1,000 |
924 |
17,129 |
| XU CHERYL | Director |
Aug 27 '24 |
Buy |
1.70 |
5,000 |
8,500 |
41,078 |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):